Advanced Cancer: Clinical Trials

618 trials for Advanced Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

323 completed, 82 recruiting, 71 unknown, 60 terminated. 318 Phase 1, 137 Not applicable, 126 Phase 2, 27 Phase 3, 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 1318Completed 178, Terminated 45, Recruiting 36, Unknown 31, Active not recruiting 17, Withdrawn 5, Not yet recruiting 3, Suspended 3
Not applicable137Completed 74, Unknown 21, Recruiting 18, Not yet recruiting 8, Active not recruiting 7, Withdrawn 4, Terminated 3, Enrolling by invitation 2
Phase 2126Completed 44, Recruiting 24, Terminated 20, Unknown 16, Active not recruiting 14, Not yet recruiting 4, Withdrawn 3, Suspended 1
Phase 327Completed 15, Recruiting 6, Terminated 2, Not yet recruiting 1, Suspended 1, Unknown 1, Withdrawn 1
Early Phase 14Completed 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 44Completed 2, Terminated 1, Unknown 1

Follow Advanced Cancer: new trials by email Literature Review of Advanced Cancer trials Research Report on Advanced Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
Pembrolizumab and either Capcecitabine + Oxaliplatin or Oxaliplatin+Leucovorin + 5-fluorouracil - Gastric Cancer, Gastroesophageal-junction Cancer
Phase 3Not yet recruitingTranscenta Therapeutics (Hangzhou) Co., Ltd.8202027-06-302026-09-29
Healing Gardens: Leveraging Serious Games to Deliver Accessible Pain-CBT and Pharmacologic Support for Patients With Advanced Cancer Managing Pain
Healing Gardens content development/refinement activities, Healing Gardens serious game - Advanced Cancer, Cancer Pain
Not applicableNot yet recruitingDana-Farber Cancer Institute462027-02-132026-09-17
The FamilyStrong Pilot Randomized Trial
FamilyStrong - Family Caregivers, Distress in Caregivers of Cancer Patients
Not applicableNot yet recruitingUniversity of Alabama at Birmingham1202027-01-012026-08-13
Symptom Trajectory Approaches to Research
Health surveys - Advanced Cancer, Metastatic Disease
Not yet recruitingUniversity of Wisconsin, Madison2282026-12-012026-09-04
Cancer Pain 101: A Digital, Asynchronous Intervention of Pain Management in Advanced Cancer
Cancer Pain 101 - Cancer, Pain
Not applicableNot yet recruitingUniversity of Alabama at Birmingham452026-11-012026-10-20
MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial
PEX010 25 mg psilocybin, PEX010 5 mg psilocybin, Standard Psilocybin-Assisted Therapy - Advanced Cancer, Demoralization
Phase 2Not yet recruitingUniversity of Calgary602026-10-302026-09-02
A Feasibility Study of a Digitally-enabled Psychological Intervention for Demoralization in Advanced Cancer Patients
A digitally-enabled positive psychological intervention for demoralization in advanced cancer patients - Advanced Cancer, Demoralization
Not applicableNot yet recruitingThe Hong Kong Polytechnic University302026-10-282026-10-13
Primary Palliative Care - a Feasibility Cluster Trial
Primary Palliative Care Complex Intervention (PrimPal) - Palliative Care, Primary Palliative Care
Not applicableNot yet recruitingUniversity of Coimbra302026-10-012026-08-03
Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
I-STAMP - Advanced Cancer, Pain
Not applicableRecruitingDana-Farber Cancer Institute732026-09-182026-10-13
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
Psilocybin (high dose), Psilocybin (low dose), PEARL Therapy - Advanced Cancer, Stage IV Solid Tumor Cancer
Phase 2Not yet recruitingUniversity Health Network, Toronto462026-09-142026-10-15
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
PF-07994525, Midazolam - Advanced Malignancies, Advanced Cancer
Phase 1RecruitingPfizer1202026-07-012026-10-13
Contrast-enhanced CBCT With C-arm HyperSight Technology
Intravenous contrast-enhanced cone beam computed tomography - Advanced Cancer
Not applicableRecruitingUniversity Health Network, Toronto202026-06-242026-06-26
Virtual Group Resilient Living Program For Patients Living With Advanced Cancer
Virtual Group Resilient Living Program (RLP), Survey Completion - Advanced Cancer
Not applicableRecruitingMayo Clinic422026-06-192026-07-02
Resilience-Building for Advance Care Planning
ROCKS, Usual Care - Advanced Cancer, End of Life
Not applicableRecruitingUniversity of Illinois at Chicago1522026-06-092026-10-08
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
Treatment plan - Advanced Cancer, Pancreatic Cancer
Not applicableRecruitingUniversity Health Network, Toronto52026-06-042026-07-30
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer
True electroacupuncture, True thumbtack needle, Sham electroacupuncture - Electroacupuncture, Chemotherapy
Not applicableNot yet recruitingAffiliated Hospital of Qinghai University2642026-05-252026-06-12
Phase 1/2 Study of UI-102 in Selected Advanced Cancers
UI-102 - Advanced Cancer
Phase 1 / Phase 2RecruitingUnited Immunity, co., Ltd.1402026-05-202026-06-03
Safety Evaluation of Bioactive Glass Based Bone Cement Combined With Ultrasound in Implantation for Metastatic Bone Tumors
Bioactive Glass Bone Cement + Ultrasound - Advanced Cancer, Pain
Not applicableNot yet recruitingLiao Yun82026-05-012026-04-20
A Pilot Randomized Controlled Trial of a Social Network Intervention
SONATA - Advanced Cancer, Older Adults (65 Years and Older)
Not applicableRecruitingUniversity of Rochester702026-04-102026-07-07
Methods of Identifying Effective Off-Guideline Treatments for Advanced Cancer Patients
Advanced Cancer
RecruitingCancer Commons3002026-03-302026-10-08

Showing 20 of 618. Sign in to see all of them.

Narrower conditions

Neoplasm Metastasis (115)  ·  Neoplasms (108)  ·  Carcinoma, Non-Small-Cell Lung (48)  ·  Pancreatic Neoplasms (32)  ·  Breast Neoplasms (26)  ·  Melanoma (26)  ·  Colorectal Neoplasms (24)  ·  Stomach Neoplasms (22)  ·  Lung Neoplasms (19)  ·  Ovarian Neoplasms (19)  ·  Pain (17)  ·  Lymphoma (16)  ·  Squamous Cell Carcinoma of Head and Neck (16)  ·  Uterine Cervical Neoplasms (15)  ·  Colonic Neoplasms (14)

Broader conditions

Neoplasms (195)  ·  Pathological Conditions, Signs and Symptoms (184)  ·  Neoplasms by Site (164)  ·  Pathologic Processes (138)  ·  Neoplastic Processes (115)  ·  Neoplasms by Histologic Type (96)  ·  Digestive System Diseases (80)  ·  Digestive System Neoplasms (79)  ·  Respiratory Tract Diseases (69)  ·  Lung Diseases (68)  ·  Respiratory Tract Neoplasms (66)  ·  Thoracic Neoplasms (66)  ·  Neoplasms, Glandular and Epithelial (59)  ·  Gastrointestinal Diseases (56)  ·  Endocrine System Diseases (55)

Interventions

Nivolumab (36)  ·  pembrolizumab (34)  ·  Gemcitabine (17)  ·  Surveys and Questionnaires (16)  ·  Ipilimumab (15)  ·  Paclitaxel (14)  ·  Bevacizumab (12)  ·  Docetaxel (12)  ·  Cisplatin (10)  ·  Irinotecan (10)  ·  abemaciclib (10)  ·  Capecitabine (9)  ·  Carboplatin (9)  ·  Pemetrexed (9)  ·  Standard of Care (9)

Sponsors

M.D. Anderson Cancer Center (66)  ·  Eli Lilly and Company (30)  ·  Bristol-Myers Squibb (23)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (14)  ·  University Health Network, Toronto (14)  ·  Dana-Farber Cancer Institute (8)  ·  Duke University (8)  ·  Mirati Therapeutics Inc. (8)  ·  Agenus Inc. (6)  ·  Centre Leon Berard (6)  ·  Massachusetts General Hospital (6)  ·  Memorial Sloan Kettering Cancer Center (6)  ·  Merck Sharp & Dohme LLC (6)  ·  Alaunos Therapeutics (5)  ·  Array Biopharma, now a wholly owned subsidiary of Pfizer (5)

Countries

United States (348)  ·  China (80)  ·  Canada (51)  ·  France (45)  ·  Australia (41)  ·  United Kingdom (39)  ·  Spain (38)  ·  Italy (32)  ·  South Korea (26)  ·  Taiwan (24)  ·  Germany (21)  ·  Belgium (19)  ·  Japan (16)  ·  Poland (15)  ·  Switzerland (13)

Top investigators

Eduardo Bruera, MD (7)  ·  Aung Naing, MD (4)  ·  David S. Hong, MD (4)  ·  Apostolia M. Tsimberidou, MD, PhD (3)  ·  Daniel Karp, MD (3)  ·  Jonathan Lewis, MD, PhD (3)  ·  Marcus L Ware, MD (3)  ·  Apostolia Tsimberidou, MD, PhD (2)

Results publications

PMID 36999619, PMID 11224527, PMID 1714502, PMID 19726226, PMID 19951879, PMID 20512358, PMID 21131552, PMID 22013950, PMID 22290823, PMID 22520742, PMID 23169523, PMID 23197081, PMID 23233708, PMID 23434733, PMID 23589315, PMID 23663868, PMID 23690414, PMID 23841031, PMID 24106841, PMID 24158411, PMID 24177180, PMID 24204627, PMID 24302090, PMID 24422672, PMID 24440085, PMID 24618336, PMID 24649963, PMID 24819685, PMID 24912489, PMID 24919854, PMID 24962353, PMID 25639187, PMID 25669829, PMID 25800762, PMID 25800768, PMID 26181019, PMID 26403509, PMID 26644411, PMID 26741729, PMID 26768772, PMID 26798966, PMID 26842696, PMID 27044938, PMID 27148765, PMID 27323902, PMID 27621408, PMID 27879972, PMID 27959684, PMID 28065465, PMID 28540640

NIH funding

2015 (11), 2018 (9), 2009 (5), 2016 (4), 2019 (4), 2017 (3), 2023 (3), R43CA132257 (2), 2008 (1), 2014 (1), F32CA278417 (1), K08CA263317 (1), K08CA266937 (1), K12CA088084 (1), K23AG076866 (1)